Clinical Trial Update: Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports remission of ICD symptoms after switching from a dopamine agonist to levodopa/carbidopa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impulse Control Disorder

Drugs mentioned

• Dopamine agonist
• Levodopa/Carbidopa (levodopa/carbidopa)

Snippet

Sponsor: Sandoz | Conditions: Impulse Control Disorder | Phase 4 | Status: COMPLETED